Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest

Effects of ADMA on gene expression and metabolism in serum-starved LoVo cells

(2016) Ningning Zheng et al.   Scientific Reports

Regulation of the p53 response and its relationship to cancer

(2015) David W. Meek   BIOCHEMICAL JOURNAL

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins

(2015) Sayo Horibe et al.   LIFE SCIENCES

Effects of flavonoids on expression of genes involved in cell cycle regulation and DNA replication in human fibroblasts

(2015) Marta Moskot et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Molecular pathways and therapeutic targets in lung cancer

(2015) Emma Shtivelman et al.   Oncotarget

Cisplatin in cancer therapy: Molecular mechanisms of action

(2014) Shaloam Dasari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Systems biology of cisplatin resistance: past, present and future

(2014) L Galluzzi et al.   Cell Death & Disease

Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer

(2014) Maimon C. Rose et al.   GENOMICS PROTEOMICS & BIOINFORMATICS

Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells

(2013) Mei Wang et al.   JOURNAL OF CHEMOTHERAPY

Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature

(2013) Martin P. Barr et al.   PLoS One

The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell

(2013) Yong Yang et al.   PLoS One

Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest

(2013) L Lundholm et al.   Cell Death & Disease

Tumor Protein 53-Induced Nuclear Protein 1 Enhances p53 Function and Represses Tumorigenesis

(2013) Jeyran Shahbazi et al.   Frontiers in Genetics

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells

(2011) M Michaelis et al.   Cell Death & Disease

The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis

(2010) Sufeng Chen et al.   LUNG CANCER

Non-Small Cell Lung Cancer Exhibits Transcript Overexpression of Genes Associated with Homologous Recombination and DNA Replication Pathways

(2009) S. Saviozzi et al.   CANCER RESEARCH

Modes of p53 Regulation

(2009) Jan-Philipp Kruse et al.   CELL

Correlation of mRNA and protein in complex biological samples

(2009) Tobias Maier et al.   FEBS LETTERS

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

(2008) Jean-Pierre Pignon et al.   JOURNAL OF CLINICAL ONCOLOGY